| Market Cap | 3.13M | P/E | - | EPS this Y | - | Ern Qtrly Grth | - |
| Income | -387.45k | Forward P/E | - | EPS next Y | - | 50D Avg Chg | 2.00% |
| Sales | 1.46M | PEG | - | EPS past 5Y | - | 200D Avg Chg | 2.00% |
| Dividend | N/A | Price/Book | N/A | EPS next 5Y | - | 52W High Chg | -31.00% |
| Recommedations | - | Quick Ratio | 0.07 | Shares Outstanding | 32.63M | 52W Low Chg | 32.00% |
| Insider Own | 62.49% | ROA | 2.71% | Shares Float | 12.24M | Beta | 0.47 |
| Inst Own | - | ROE | - | Shares Shorted/Prior | -/- | Price | 0.10 |
| Gross Margin | 90.08% | Profit Margin | -4.77% | Avg. Volume | 727 | Target Price | - |
| Oper. Margin | -20.78% | Earnings Date | May 12 | Volume | 25,000 | Change | 0.00% |
Vycor Medical, Inc. designs, develops, and markets neurological medical devices and therapies in the United States and Europe. It operates in two segments, Vycor Medical and NovaVision. The Vycor Medical segment provides devices for neurosurgery comprising ViewSite Brain Access System, a retraction and access system for brain and spine surgeries. The NovaVision segment offers non-invasive computer-based rehabilitation targeted at people who have impaired vision as a result of stroke or other brain injury. Vycor Medical, Inc. has a license and transition agreement with HelferApp GmbH, which grants HelferApp the license to provide NovaVision's products and therapies to patients and professionals in Austria and Switzerland. The company primarily serves hospitals and medical professionals. Vycor Medical, Inc. was founded in 2005 and is headquartered in Boca Raton, Florida. Vycor Medical, Inc. is a subsidiary of Fountainhead Capital Management Limited.